HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Charalambos Zisis Ion Bellenis Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zisis, C. Articles by Bellenis, I. Search for Related Content PubMed PubMed Citation Articles by Zisis, C. Articles by Bellenis, I.

J Thorac Cardiovasc Surg 2005;130:1201-1202
© 2005 The American Association for Thoracic Surgery

Brief Communication

Lymphangiomatous hamartoma: Cause or bystander of the isolated chylopericardium?

^a Department of Thoracic Surgery, Evangelismos General Hospital, Athens, Greece
^b Department of Pathology, Evangelismos General Hospital, Athens, Greece
^c Intensive Care and Coronary Care Unit, "Venizelio" Hospital, Iraklion, Crete, Greece.

Received for publication April 29, 2005; accepted for publication May 20, 2005.

^_* Address for reprints: Charalambos Zisis, MD, PhD, 17A, Patriarchou Grigoriou str, 166 74 Glyfada, Greece. (Email: chzisis@otenet.gr).

The first 20% of the full text of this article appears below.

Isolated chylopericardium is an extremely rare pathologic entity, and about its cause there is a series of reasons sporadically reported in the literature. Lymphangiomatous hamartoma, a benign tumor of lymphangiomatous origin sparsely located exclusively to the mediastinum, has been considered one of the causes of the chylopericardium.

Clinical Summary

A 25-year-old male smoker of 7 pack-years was referred to our department from a district hospital for rapidly recurrent pericardial effusion (Figure 1) diagnosed 15 days before and showing no response to medication. During the 2 previous days, this progressively increasing effusion had caused clinical and echocardiographic features of pericardial tamponade and had been submitted twice to pericardiocentesis, with removal of 2.5 L and 800 mL of milky fluid, respectively. The laboratory results of the fluid revealed the following: triglycerides, 944 mg/dL; cholesterol, 76 mg/dL; glucose, 116 mg/dL; total proteins, 3.7 g/dL; and lactic dehydrogenase, 707 U/L. Computed tomography of the chest confirmed the pericardial effusion, and the patient . . . [Full Text of this Article]

This article has been cited by other articles:

				C. Dib, A. J. Tajik, S. Park, M. E.L. Kheir, B. Khandieria, and F. Mookadam Chylopericardium in adults: A literature review over the past decade (1996-2006) J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 650 - 656. [Abstract] [Full Text] [PDF]

				C. Zisis, K. Spiliotopoulos, M. Patronis, G. Filippakis, G. Stratakos, G. Tzelepis, and I. Bellenis Diffuse lymphangiomatosis: Are there any clinical or therapeutic standards? J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1664 - 1665. [Full Text] [PDF]